| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Nov 24, 2025 |
Ultragenyx Pharmaceutical Inc.
RARE
|
BUY |
$50.00
Est. +49%
|
$33.59 | $39.89 |
Pending
|
$14.85
-55.8%
|
| Nov 11, 2025 |
4D Molecular Therapeutics Inc
FDMT
|
BUY |
$33.00
Est. +224%
|
$10.17 | $16.34 |
Pending
|
$14.70
+44.5%
|
| Nov 05, 2025 |
PTC Therapeutics Inc
PTCT
|
BUY |
$68.00
Est. +0%
|
$67.72 | $90.86 |
Target Met
|
$71.40
+5.4%
|
| Nov 04, 2025 |
Vertex Pharmaceuticals, Inc.
VRTX
|
SELL |
$414.00
Est. +3%
|
$426.00 | $403.16 (Low) |
Precision Hit (±3%)
|
$557.96
-31.0%
|
| Oct 28, 2025 |
Intellia Therapeutics Inc
NTLA
|
BUY |
$24.00
Est. +62%
|
$14.79 | $18.48 |
Pending
|
$12.68
-14.3%
|
| Oct 17, 2025 |
Cellectis - ADR
CLLS
|
BUY |
$8.00
Est. +77%
|
$4.52 | $5.36 |
Pending
|
$3.32
-26.5%
|
| Oct 06, 2025 |
Cytokinetics Inc
CYTK
|
BUY |
$82.00
Est. +44%
|
$56.97 | $88.31 |
Target Met
|
$73.95
+29.8%
|
| Sep 25, 2025 |
Kodiak Sciences Inc
KOD
|
BUY |
$17.00
Est. +10%
|
$15.49 | $47.84 |
Target Met
|
$36.36
+134.7%
|
| Sep 23, 2025 |
Ionis Pharmaceuticals Inc
IONS
|
BUY |
$82.00
Est. +34%
|
$61.36 | $86.74 |
Target Met
|
$58.13
-5.3%
|
| Sep 03, 2025 |
Cytokinetics Inc
CYTK
|
BUY |
$71.00
Est. +42%
|
$49.99 | $88.31 |
Target Met
|
$73.95
+47.9%
|
| Sep 02, 2025 |
Ionis Pharmaceuticals Inc
IONS
|
BUY |
$78.00
Est. +36%
|
$57.49 | $86.74 |
Target Met
|
$58.13
+1.1%
|
| Jul 22, 2025 |
Sarepta Therapeutics Inc
SRPT
|
BUY |
$18.00
Est. +35%
|
$13.32 | $25.32 |
Target Met
|
$22.99
+72.6%
|
| Apr 24, 2025 |
Cytokinetics Inc
CYTK
|
BUY |
$55.00
Est. +36%
|
$40.33 | $70.98 |
Target Met
|
$73.95
+83.4%
|
| Nov 05, 2024 |
Editas Medicine Inc
EDIT
|
BUY |
$5.00
Est. +60%
|
$3.12 | $4.54 |
Miss
|
$3.08
-1.3%
|
| Oct 15, 2024 |
Legend Biotech Corp - ADR
LEGN
|
BUY |
$94.00
Est. +109%
|
$44.91 | $51.77 |
Miss
|
$21.75
-51.6%
|
| Oct 04, 2024 |
Biomarin Pharmaceutical Inc. - Registered Shares
BMRN
|
BUY |
$86.00
Est. +24%
|
$69.51 | $73.51 |
Miss
|
$66.43
-4.4%
|
| Sep 16, 2024 |
Biomarin Pharmaceutical Inc. - Registered Shares
BMRN
|
BUY |
$110.00
Est. +57%
|
$69.86 | $77.60 |
Miss
|
$66.43
-4.9%
|
| Aug 08, 2024 |
Sarepta Therapeutics Inc
SRPT
|
BUY |
$203.00
Est. +45%
|
$140.06 | $144.22 |
Miss
|
$22.99
-83.6%
|
| Aug 06, 2024 |
Biocryst Pharmaceuticals Inc.
BCRX
|
SELL |
$7.00
Est. +7%
|
$7.51 | $6.02 (Low) |
Target Met
|
$10.09
-34.4%
|
| Aug 02, 2024 |
Vir Biotechnology Inc
VIR
|
BUY |
$28.00
Est. +188%
|
$9.73 | $14.45 |
Miss
|
$11.45
+17.7%
|
| Jun 13, 2024 |
Sarepta Therapeutics Inc
SRPT
|
BUY |
$185.00
Est. +54%
|
$119.98 | $155.95 |
Miss
|
$22.99
-80.8%
|
| May 21, 2024 |
Vir Biotechnology Inc
VIR
|
BUY |
$27.00
Est. +179%
|
$9.69 | $14.45 |
Miss
|
$11.45
+18.2%
|
| May 16, 2024 |
Solid Biosciences Inc
SLDB
|
BUY |
$18.00
Est. +86%
|
$9.69 | $10.37 |
Miss
|
$10.42
+7.5%
|
| Apr 15, 2024 |
4D Molecular Therapeutics Inc
FDMT
|
BUY |
$45.00
Est. +71%
|
$26.35 | $28.93 |
Miss
|
$14.70
-44.2%
|
| Nov 02, 2022 |
Arcturus Therapeutics Holdings Inc
ARCT
|
BUY |
$25.00
Est. +15%
|
$21.69 | - | - |
$15.56
-28.3%
|
| Aug 23, 2022 |
Biocryst Pharmaceuticals Inc.
BCRX
|
SELL |
$14.00
Est. +2%
|
$14.33 | - | - |
$10.09
+29.6%
|
| Aug 22, 2022 |
Bluebird bio Inc
BLUE
|
SELL |
$5.00
Est. +14%
|
$5.83 | $55.60 (Low) |
Miss
|
$4.97
+14.8%
|
| Feb 24, 2022 |
Moderna Inc
MRNA
|
BUY |
$210.00
Est. +34%
|
$156.23 | - | - |
$148.87
-4.7%
|
| Feb 10, 2022 |
Seagen Inc
SGEN
|
SELL |
$120.00
Est. +4%
|
$124.93 | - | - |
$228.74
-83.1%
|
| Nov 04, 2021 |
Ionis Pharmaceuticals Inc
IONS
|
SELL |
$33.00
Est. +5%
|
$34.63 | - | - |
$58.13
-67.9%
|
| Oct 28, 2021 |
Alnylam Pharmaceuticals Inc
ALNY
|
BUY |
$210.00
Est. +30%
|
$162.14 | - | - |
$264.50
+63.1%
|
| Aug 05, 2021 |
Intellia Therapeutics Inc
NTLA
|
BUY |
$207.00
Est. +25%
|
$165.16 | - | - |
$12.68
-92.3%
|
| Aug 03, 2021 |
Ultragenyx Pharmaceutical Inc.
RARE
|
BUY |
$141.00
Est. +68%
|
$83.77 | - | - |
$14.85
-82.3%
|
| Jun 11, 2021 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$285.00
Est. +48%
|
$193.02 | - | - |
$557.96
+189.1%
|